Stay Ahead of the Game With Alcon (ALC) Q2 Earnings: Wall Street's Insights on Key Metrics

Core Viewpoint - Analysts project Alcon (ALC) will report quarterly earnings of $0.71 per share, a decline of 4.1% year over year, with revenues expected to reach $2.61 billion, an increase of 5.2% from the same quarter last year [1]. Earnings Projections - Revisions to earnings projections are crucial for predicting investor behavior regarding the stock, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock price performance [2]. Key Metrics Estimates - Analysts forecast 'Net Sales- Total Surgical' to reach $1.48 billion, indicating a year-over-year change of +4.3% [4]. - 'Net Sales- Total Vision Care' is expected to reach $1.13 billion, reflecting a change of +6.6% from the previous year [4]. - 'Net Sales- Total Surgical- Consumables' is projected at $786.91 million, with a year-over-year change of +6.9% [4]. - 'Net Sales- Total Surgical- Equipment/other' is estimated to be $232.70 million, showing a year-over-year change of +4.4% [5]. - 'Net Sales- Total Vision Care- Contact lenses' is expected to reach $682.51 million, indicating a change of +7.3% year over year [5]. - 'Net Sales- Total Vision Care- Ocular health' is projected at $446.40 million, reflecting a year-over-year change of +5.5% [5]. - 'Net Sales- Total Surgical- Implantables' is expected to be $464.21 million, with a minimal year-over-year change of +0.1% [6]. - 'Revenues- Other revenues' are projected to reach $17.22 million, indicating a significant year-over-year change of +23% [6]. - 'Net sales by region- United States' is estimated at $1.18 billion, reflecting a year-over-year change of +3% [6]. - 'Net sales by region- International' is expected to be $1.45 billion, indicating a year-over-year change of +7.9% [7]. Stock Performance - Alcon shares have shown a return of -0.5% over the past month, contrasting with the Zacks S&P 500 composite's +3.5% change, and the company holds a Zacks Rank 4 (Sell), suggesting it may underperform the overall market in the near future [7].